Mycobacterium avium causes disseminated infection in patients with acquired immune deficieny syndrome. Mycobacterium tuberculosis is a pathogen associated with the deaths of millions of people worldwide annually. Effective therapeutic regimens exist that are limited by the emergence of drug resistance and the inability of antibiotics to kill dormant organisms. The present study describes a system using Mycobacterium smegmatis, an avirulent mycobacterium, to deliver the lytic phage TM4 where both M. avium and M. tuberculosis reside within macrophages. These results showed that treatment of M. avium-infected, as well as M. tuberculosis-infected, RAW 264.7 macrophages, with M. smegmatis transiently infected with TM4, resulted in a significant time-and titer-dependent reduction in the number of viable intracellular bacilli. In addition, the M. smegmatis vacuole harboring TM4 fuses with the M. avium vacuole in macrophages. These results suggest a potentially novel concept to kill intracellular pathogenic bacteria and warrant future development.
addition, M. avium infection has been described with increasing frequency in non-AIDS populations [6, 7] .
One of the hallmark characteristics of M. avium is its resistance to most of the antituberculosis drugs [8, 9] , and only recently have a small number of compounds, such as the new macrolides (azithromycin, clarithromycin, and roxithromycin), been shown to have activity against the bacterium in vitro and in humans [10] [11] [12] . Despite the activity of macrolides, the challenge for medical practitioners persists, since those drugs are used for prolonged periods as prophylaxis for the infection, and, once resistance develops, it is generalized toward all macrolides, and effective alternative drug treatment is suboptimal [13] .
It is, therefore, paramount that new drugs as well as new forms of therapy be investigated. We hypothesized, on the basis of a number of studies used in the past to treat extracellular bacterial infections such as Escherichia coli [14] , that the use of a mycobacteriophage might be useful as either part of an antimycobacterial regimen or by itself. In the present report, we show that TM4, a lytic bacteriophage that does not form stable lysogens, can be delivered by a transiently-infected nonvirulent mycobacterium to kill both M. tuberculosis and M. avium inside macrophages [15, 16] .
Materials and Methods
Mycobacteria and mycobacteriophage. M. avium strain 109 was isolated from the blood sample of a patient with AIDS and demonstrated to be virulent in the mouse model of M. avium infection (data not shown). M. avium 109 was chosen for these studies be- cause it can be infected with the bacteriophage TM4, as reported elsewhere [16] . A spontaneous kanamycin-resistant (R) M. avium 109 was isolated by selection on plates containing 400 mg/mL kanamycin. The use of kanamycin-R M. avium helped in distinguishing between M. avium and M. smegmatis after plating. The phenotype was verified to be stable, and virulent assay in macrophage showed that the kanamycin-R M. avium was as virulent as the wild-type strain (data not shown). M. tuberculosis H37Rv was purchased from American Type Culture Collection. A spontaneous kanamycin-R M. tuberculosis was also isolated by selection on plates containing 400 mg/mL kanamycin. The phenotype was determined to be stable. M. smegmatis mc 2 155 was a gift from William Jacobs, Jr. (Albert Einstein College of Medicine, Bronx, New York). Bacteria were grown on Middlebrook 7H11 agar plates supplemented with oleic acid, albumin, dextrose, and catalase, and individual colonies were subcultured in 7H9 broth for 5 days (M. avium and M. tuberculosis) or 1 day (M. smegmatis). Bacteria were washed with Hank's balanced salt solution (HBSS) and processed to avoid clump formation, as reported elsewhere [17] . The dispersion of the inoculum and the viability of the organisms were verified by microscopy using the LIVE-DEAD assay (Molecular Probes), as described elsewhere [17] .
Phage TM4 was propagated in M. smegmatis, as described by Jacobs, Jr. et al. [18] and Foley-Thomas et al. [16] . In brief, phage lysates (10 5 pfu/mL) were incubated with fresh cultures of M. smegmatis (10 7 cfu) at room temperature for 30 min. 7H9 soft agar was then added, and the cells were plated on 7H11 agar by use of the soft agar layer method and incubated at 37ЊC for 2 days or as described elsewhere [16] . Phage titers were determined at dilutions that gave single isolated plaques, to exclude the possibility of lysis from other sources.
Macrophages. ) containing ∼ 7 pfu/mL of phage 5 ϫ 10 7.8 ϫ 10 (M. avium) and 7 pfu/mL of phage (M. tuberculosis) or M. 7.5 ϫ 10 smegmatis without phage. The titer of the phage was confirmed by plating M. smegmatis infected with TM4 for plaques. The extracellular bacteria were removed by extensive washing (HBSS), and the cell cultures were harvested after 2 and 4 days to quantify the viable intracellular bacteria.
The numbers of macrophages on the monolayers were monitored throughout the experiment, as described elsewhere [17] . Approximately 10% of the cells detached after 4 days of infection. The percentage of macrophages infected with M. avium after 2 h of incubation varied from (with the bacteria-to-cell ratio 46% ‫ע‬ 6% of 1:1) to (with the bacteria-to-cell ratio of 10:1), 68% ‫ע‬ 9% whereas the percentage of macrophages infected with M. tuberculosis after 2 h ranged from (1:1 ratio of bactera to 40% ‫ע‬ 4% cells) to (10:1 ratio of bacteria to cells). 73% ‫ע‬ 6% Quantitation of intracellular bacteria. The number of intracellular bacteria was determined 2 and 4 days following coinfection with M. smegmatis-infected transiently with TM4, M. smegmatis only, or phage TM4 only, as described elsewhere [13] . The lysate was serially diluted and plated onto 7H11 agar containing 50 mg/ mL kanamycin (a concentration that prevents M. smegmatis growth). The plates were incubated for 10 days, and the colonyforming unit count was determined. When plated on agar without kanamycin, it was observed that ∼30% of M. smegmatis and ∼20% of M. smegmatis were alive by day 2 and 4, respectively.
Observation of intracellular bacteria. To investigate a possible mechanism by which phages are delivered to M. avium vacuoles within macrophages, RAW 264.7 macrophage monolayers were infected with M. avium 109 and, after 24 h, coinfected with M. smegmatis. Cultures were maintained for 4 days and either observed daily using video microscopy or fixed with 2% paraformaldehyde, as described elsewhere [17] . We used 2 approaches. First, because M. avium is a short bacillus when cultured to logarithmic phase of growth and M. smegmatis is a long rod, both bacteria can be easily distinguished within cells. Therefore, the first approach was to determine, by real-time video microscopy (Optronics; DEI-700) and by phase contrast microscopy (Nikon OPTIPHOT) if both bacteria could coinhabit the same vacuole. As a variant of this approach, in some experiments, M. smegmatis was labeled with fluoresceintagged succinimidyl ester (Molecular Probes) for 1 h and then used in video assays. The dye only stains viable cells. Second, by relying on the fact that M. avium vacuole does not acidify and M. smegmatis vacuole is acidic, we used acridine orange (Sigma Chemical) to determine whether fusion of both vacuoles would occur. In brief, macrophage monolayers were infected with M. avium and 24 h later coinfected with M. smegmatis for 4 days. The monolayers were incubated with acridine orange for 10 min using a protocol described elsewhere [19] . After washing, the slides were mounted and observed by fluorescent microscopy. M. avium is usually found in a non-acidic environment, and, therefore, the vacuole would not incorporate acridine orange. In contrast, M. smegmatis environment is acidic and therefore stains green-yellow. In case the M. smegmatis vacuole would fuse with the M. avium vacuole, M. avium and M. smegmatis would share the resulting compartment. It potentially would be acidic, and both bacteria would stain with acridine orange.
To determine whether intracellular M. tuberculosis was killed after M. smegmatis/TM4 treatment, infected monolayers in Lab-Tek Slides (Nunc) were fixed after the assay with 2% paraformaldehyde and stained by the Kinyoun method, as described elsewhere [17] .
Statistical analysis. The assays were repeated at least 3 times, and the results were expressed as . Comparisons bemean ‫ע‬ SD tween groups at the same time point were analyzed using the MannWhitney nonparametric test.
Results
Mycobacteriophage TM4 kills extracellular M. avium and M. tuberculosis in vitro. We have shown that M. avium strain MAC 109 is infected by the TM4-derived luciferase reporter phages phAE39 and phAE40 [16] . To verify that the phage infection results in lytic killing in vitro, strain MAC 109 was infected with mycobacteriophage TM4, and the bactericidal effect of TM4 was measured over time. MAC 109 ( 5 ) was infected 1 ϫ 10 with 5 or 7 pfu of mycobacteriophage TM4, and, at 1 ϫ 10 1 ϫ 10 various time points, phage absorption was stopped by centrifugation at 4ЊC for 10 min, and the pellet was resuspended in HBSS and plated onto 7H11 agar. The kill curve demonstrates that mycobacteriophage TM4 effectively kills MAC 109 in vitro with a 50% reduction in the number of viable bacilli observed after 120 min of phage infection (figure 1). The same method was used with M. tuberculosis, with the killing observed being even greater, with ∼30-fold reduction in the number of viable bacteria after 4 h following phage infection (figure 1).
Mycobacteriophage TM4 alone cannot kill intracellular mycobacteria. Phage therapy of an intracellular infection would , and 10 7 pfu). M. avium continue to grow intracellularly, similarly to the growth observed in macrophage monolayers that received no treatment suggesting no effect of the phage ( figure 2) .
Effect of phage TM4 delivered intracellularly against M. avium. To deliver TM4 to the intracellular environment of macrophages, we used as a vehicle M. smegmatis, a nonpathogenic mycobacterium, infected with TM4. It was postulated that M. smegmatis/TM4 would be ingested by M. avium-infected macrophages and potentially deliver the phage to the site of M. avium in macrophages. To address this hypothesis, we used M. smegmatis infected for 30 min with 5 or 7 pfu 7.8 ϫ 10 7.8 ϫ 10 to treat macrophage monolayers that had been infected with M. avium for 24 or 48 h. As shown in figure 3 , the use of M. smegmatis infected with TM4 ( 7 pfu) for 30 min to treat 7.8 ϫ 10 macrophage-monolayers previously infected with M. avium for 24 h resulted in significant inhibitory activity at 2 days and killing of the intracellular M. avium at 4 days. Treatment with TM4 at a titer of 5 pfu was associated with an average 7.8 ϫ 10 30%-40% less (but still significant) anti-M. avium activity than 7 pfu (data not shown). 7.8 ϫ 10 Figure 4 shows the effect of M. smegmatis-TM4 in macrophages infected with M. avium for 48 h prior to treatment.
Although a 10-fold decrease was observed when macrophages were treated with M. smegmatis-TM4 after 24 h of infection, a 100-fold decrease in the number of intracellular M. avium was seen as the result of treatment of infected monolayers with M. smegmatis-TM4 after 48 h of infection with M. avium ( figure  4) . In contrast, treatment with M. smegmatis without TM4 infection did not result in a significant inhibition or killing of intracellular M. avium. Control samples were tested to determine the number of viable cells. Infection of RAW 246.7 cells was not associated with decreased viability of the monolayer (data not shown).
M. smegmatis TM4 kills intracellular M. tuberculosis. To determine the effect of TM4 on intracellular M. tuberculosis, RAW 264.7 cells were infected with H37Rv, and 24 h after infection, treated with M. smegmatis, TM4 or M. smegmatis-infected with TM4 (M. smegmatis TM4, 7 pfu) for 6.7 ϫ 10 2 and 4 days. As shown in figure 5 , while neither M. smegmatis nor TM4 treatment was associated with decrease in viable intracellular M. tuberculosis, M. smegmatis TM4 resulted in ∼10-fold reduction after 2 days and ∼100-fold reduction in the number of intracellular bacteria after 4 days. The decrease in the number of intracellular M. tuberculosis was confirmed by light microscopy (data not shown).
Coinfection of macrophages with M. avium and M. smegmatis-TM4 results in fusion of the infected vacuoles. To elucidate the mechanisms by which M. smegmatis delivers the TM4 lytic phage to intracellular M. avium, we monitored the RAW 264.7 macrophage coinfection using time-lapse video microscopy. The use of this technique allowed us to observe where M. smegmatis taken up by macrophage went into the cell. Macrophage monolayers were infected with M. avium and coinfected with M. smegmatis 24 h later. Because M. avium grown to logarithmic phase is a short bacilli and M. smegmatis is always a long rod, it was feasible to follow the dynamics of the infection daily by real-time video microscopy. As shown in figure 6A, using this method, we could detect the fusion of M. avium and M. smegmatis vacuoles. In addition, we used acridine orange, a dye that concentrates in acidic compartments in the macrophages, to detect the fusion of M. avium and M. smegmatis vacuoles. Figures 6B, 6C , and 6D show that, in macrophages infected with M. smegmatis, the vacuole is acidic and therefore the bacterium stains green. In contrast, in macrophages infected with M. avium alone, we do not see the bacterium, which does not stain. Macrophages coinfected with M. avium and M. smegmatis ( figure 6D ) have M. avium in an acidic environment, which, in the figure, is shown by the appearance of green small rods characteristic of M. avium. became available, killing of the bacteria in deep tissues (i.e., bone marrow) usually is not achieved [20] . In addition to the problem of M. avium and M. tuberculosis resistance to antibiotics, both bacteria are able to infect and grow within macrophages and monocytes, and in vivo undergo a latent or dormant phase of infection in the host [1] . A limitation of most antimicrobial agents is that their modes of action require having the microbial target in active replication.
Discussion
Phage therapy to treat an infectious disease was conceived many years ago with limited success. Phages are specific to microorganisms and, even within a species, can fail to infect some strains [15, 16] . In addition, they need to be in the same environment as the pathogen to be able to infect it. Since phages, in contrast to antimicrobials, are not diffusable across membranes, strategies need to be devised to deliver the phage to the intracellular pathogen. Nevertheless, Sula et al. reported that the phage DS-6A was effective in killing M. tuberculosis in guinea pigs after parenteral administration [21] . A possible explanation for this result might have been that some M. tuberculosis cells were infected with the phage while extracellularly within the animals (e.g., in the extracellular milieu of the pulmonary cavity). In this scenario, transiently phage-infected M. tuberculosis cells may have delivered the phage to M. tuberculosis bacilli within macrophages. Nonetheless, this observation needs to be further substantiated.
Our results show that, when delivered to the site where the pathogenic bacterium resides inside the macrophages, TM4 was effective in lysing M. avium and, even more significantly, M. tuberculosis. In fact, the decrease in bacterial numbers after 4 days was similar to or better than the anti-M. avium effect obtained with macrolides clinically used as antituberculosis drugs in the same system [22, 23] . We had similar but more compelling results with M. tuberculosis. Because not all M. avium vacuoles fused with M. smegmatis vacuoles after 4 days (figure 6A), it is possible that longer period of observation would lead to increased killing. Although both M. avium and M. tuberculosis inhibit phagosome-lysosome fusion in macrophages [24, 25] , it is known that the mycobacterial vacuole still retains its ability to fuse with endosomes [26] . A recent study demonstrated that, in macrophages coinfected with M. avium or M. tuberculosis and Coxiella burnetti, fusion of the 2 vacuoles was observed after a period of ∼24 h [27] . Interestingly, in this case, the new vacuole created after fusion, containing Coxiella and mycobacteria, was also acidic [27] . This seems to be the case in our experiments, in which the vacuoles containing M. avium and M. smegmatis incorporated acridine orange. Another possible explanation would be that the TM4 phage reached the M. avium vacuole by another mechanism and that, after lysing, the bacterium the vacuole then became acidic. Although possible, this explanation does not agree with our observation by video microscopy (fused vacuoles), indicating the presence of fused vacuoles.
In the present study, we described a novel strategy to deliver lytic phage to M. avium, as well as M. tuberculosis, vacuoles within macrophages. Our results show that this method of delivery can be useful and, above all, that the potential of this form of therapy needs to be explored. Although M. smegmatis certainly may not be the ideal delivery system, the results shown in this study can be seen as "proof of concept," and future studies should address this question. We are currently exploring the use of other mycobacteriophages and attenuated mycobacterial strains of M. avium and M. tuberculosis, as well as bacille Calmette-Guerin as potential phage delivery systems. Other delivery systems need to be developed if the administration of treatment into the airways proves to be efficacious.
